Atlas Trials

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Clinical trial NCT07284901 · RECRUITING

Trial details

NCT number
NCT07284901
Sponsor
Kailera
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity With DiabetesOverweight With Diabetes
Start date
2026-01-12
Primary completion
2028-03-27
Enrollment
1156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.